PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34822033-0	2021	USP39 attenuates the antitumor activity of cisplatin on colon cancer cells dependent on p53.	Cisplatin	43-52	tumor protein p53	Homo sapiens	88-91	
34822033-9	2021	Further studies show that USP39 regulates cisplatin-induced apoptosis dependent on p53.	Cisplatin	42-51	tumor protein p53	Homo sapiens	83-86	
34822033-11	2021	Collectively, our findings reveal that USP39 might be a negative factor of the p53 mediated cisplatin sensitivity of colon cancer, and suggest USP39 as a potential molecular target for cisplatin chemotherapy of colon cancer.	Cisplatin	92-101	tumor protein p53	Homo sapiens	79-82	
34822033-11	2021	Collectively, our findings reveal that USP39 might be a negative factor of the p53 mediated cisplatin sensitivity of colon cancer, and suggest USP39 as a potential molecular target for cisplatin chemotherapy of colon cancer.	Cisplatin	185-194	tumor protein p53	Homo sapiens	79-82